Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study-Reference-Cited by-同舟云学术

Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study

Published:2016-08-23 Issue:1 Volume:16 Page:
ISSN:1471-2377
Container-title:BMC Neurology
language:en
Short-container-title:BMC Neurol

Author:

Pohlmann-Eden Bernd,Marson Anthony G.,Noack-Rink Matthias,Ramirez Francisco,Tofighy Azita,Werhahn Konrad J.,Wild Imane,Trinka Eugen

Funder

UCB Pharma

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12883-016-0663-7

Reference42 articles.

1. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935–1984. Epilepsia. 1993;34:453–68.

2. Sillanpaa M, Kalviainen R, Klaukka T, Helenius H, Shinnar S. Temporal changes in the incidence of epilepsy in Finland: nationwide study. Epilepsy Res. 2006;71:206–15.

3. Sillanpaa M, Lastunen S, Helenius H, Schmidt D. Regional differences and secular trends in the incidence of epilepsy in Finland: a nationwide 23-year registry study. Epilepsia. 2011;52:1857–67.

4. Arain AM, Abou-Khalil BW. Management of new-onset epilepsy in the elderly. Nat Rev Neurol. 2009;5:363–71.

5. Pohlmann-Eden B. Issues when treating epilepsy in the elderly. Acta Neurol Scand Suppl. 2005;181:40–6.

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the Incidence Rate of Neuropsychiatric Adverse Effects in Older Adults Following Levetiracetam Initiation: A Retrospective Study;International Journal of General Medicine;2024-05

2. Analysis of the global burden of disease study highlights the global, regional, and national trends of idiopathic epilepsy epidemiology from 1990 to 2019;Preventive Medicine Reports;2023-12

3. The evolution of antiseizure medication therapy selection in adults: Is artificial intelligence -assisted antiseizure medication selection ready for prime time?;Journal of Central Nervous System Disease;2023-10-18

4. Post-stroke epileptic seizures: risk factors, clinical presentation, principles of diagnosis and treatment;Epilepsy and paroxysmal conditions;2023-07-09

5. Antiseizure medications in the World Health Organization list of “essential medicines”;Epilepsia;2023-05-23